[ACS] From KRASG12Dto Pan-KRAS Inhibitors岸A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design

black_opium63 Post time 5 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-30 02:10
Reward10points

journalㄩJournal of Medicinal Chemistry

AuthorsㄩXiaoshen Ma; David L. Sloman; Timothy J. Henderson; D. Jonathan Bennett; Gianni Chessari; Philip J. Day; Ruchia Duggal; Emma Edelstein; Symon Gathiaka; Andrew Hoover; Steven Howard; Shuhei Kawamura; Yu Kobayakawa; Brian M. Lacey; Thomas W. Lyons; My S. Mansueto; Richard Miller; Shinji Mizuarai; Erik V. Munsell; Marc O*Reilly; Tsuyoshi Oshima; Ryan D. Otte; Anandan Palani; David C. Rees; Takeshi Sagara; Aaron Sather; Patrick Schopf; Kazuaki Shibata; Yuki Shikata; Nicolas Solban; Sriraman Venkataraman; Dan Su; Uma Swaminathan; Yingchun Ye; Alexander Stoeck; Yongxin Han

Published dateㄩ2026-4-23

DOIㄩ10.1021/acs.jmedchem.5c03662

PDF linkㄩhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03662

Article linkㄩhttps://doi.org/10.1021/acs.jmedchem.5c03662

Article SourceㄩAmerican Chemical Society (ACS)﹝


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time 5 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    40

Return to the list